The Design and Implementation of A5146, a Prospective Trial Assessing the Utility of Therapeutic Drug Monitoring Using an Inhibitory Quotient in Antiretroviral-Experienced HIV-Infe...

Por Demeter, Lisa M., Mukherjee, A. Lisa, DiFrancesco, Robin, Jiang, Hongyu, DiCenzo, Robert, Bastow, Barbara, Rinehart, Alex R., Morse, Gene D., Albrecht, Mary
Publicado em 2008

Comparison of Population and 454 “Deep” Sequence Analysis for HIV Type 1 Tropism Versus the Original Trofile Assay in Non-B Subtypes

Por Lee, Guinevere Q., Harrigan, P. Richard, Dong, Winnie, Poon, Art F.Y., Heera, Jayvant, Demarest, James, Rinehart, Alex, Chapman, Doug, Valdez, Hernan, Portsmouth, Simon
Publicado em 2013

Quality Assessment for Therapeutic Drug Monitoring in AIDS Clinical Trials Group (ACTG 5146): A Multicenter Clinical Trial

Por DiFrancesco, Robin, Rosenkranz, Susan, Mukherjee, A. Lisa, Demeter, Lisa M., Jiang, Hongyu, DiCenzo, Robert, Dykes, Carrie, Rinehart, Alex, Albrecht, Mary, Morse, Gene D.
Publicado em 2010

A Randomized Trial of Therapeutic Drug Monitoring of Protease Inhibitors in Antiretroviral-Experienced, HIV-1-Infected Patients

Por Demeter, Lisa M., Jiang, Hongyu, Mukherjee, A. Lisa, Morse, Gene D., DiFrancesco, Robin, Dykes, Carrie, Sista, Prakash, Bacheler, Lee, Klingman, Karin, Rinehart, Alex, Albrecht, Mary
Publicado em 2009

Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment

Por Stellbrink, Hans-Jürgen, Le Fevre, Eric, Carr, Andrew, Saag, Michael S., Mukwaya, Geoffrey, Nozza, Silvia, Valluri, Srinivas Rao, Vourvahis, Manoli, Rinehart, Alex R., McFadyen, Lynn, Fichtenbaum, Carl, Clark, Andrew, Craig, Charles, Fang, Annie F., Heera, Jayvant
Publicado no AIDS (2016)

PHASE 2 SAFETY AND TOLERABILITY STUDY OF MARAVIROC-CONTAINING REGIMENS TO PREVENT HIV INFECTION IN WOMEN (HPTN 069/ACTG A5305): A RANDOMIZED TRIAL

Por Gulick, Roy M., Wilkin, Timothy J., Chen, Ying Q., Landovitz, Raphael J., Amico, K. Rivet, Young, Alicia M., Richardson, Paul, Marzinke, Mark A., Hendrix, Craig W., Eshleman, Susan H., McGowan, Ian, Cottle, Leslie M., Andrade, Adriana, Marcus, Cheryl, Klingman, Karin L., Chege, Wairimu, Rinehart, Alex R., Rooney, James F., Andrew, Philip, Salata, Robert A., Siegel, Marc, Manabe, Yukari C., Frank, Ian, Ho, Ken, Santana, Jorge, Stekler, Joanne D., Swaminathan, Shobha, McCauley, Marybeth, Hodder, Sally, Mayer, Kenneth H.
Publicado no Ann Intern Med (2017)

Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)

Por Gulick, Roy M., Wilkin, Timothy J., Chen, Ying Q., Landovitz, Raphael J., Amico, K. Rivet, Young, Alicia M., Richardson, Paul, Marzinke, Mark A., Hendrix, Craig W., Eshleman, Susan H., McGowan, Ian, Cottle, Leslie M., Andrade, Adriana, Marcus, Cheryl, Klingman, Karin L., Chege, Wairimu, Rinehart, Alex R., Rooney, James F., Andrew, Philip, Salata, Robert A., Magnus, Manya, Farley, Jason E., Liu, Albert, Frank, Ian, Ho, Ken, Santana, Jorge, Stekler, Joanne D., McCauley, Marybeth, Mayer, Kenneth H.
Publicado no J Infect Dis (2017)